Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies
- PMID: 32291399
- PMCID: PMC7156231
- DOI: 10.1038/s41379-020-0536-x
Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies
Abstract
Data on pathologic changes of the 2019 novel coronavirus disease (COVID-19) are scarce. To gain knowledge about the pathology that may contribute to disease progression and fatality, we performed postmortem needle core biopsies of lung, liver, and heart in four patients who died of COVID-19 pneumonia. The patients' ages ranged from 59 to 81, including three males and one female. Each patient had at least one underlying disease, including immunocompromised status (chronic lymphocytic leukemia and renal transplantation) or other conditions (cirrhosis, hypertension, and diabetes). Time from disease onset to death ranged from 15 to 52 days. All patients had elevated white blood cell counts, with significant rise toward the end, and all had lymphocytopenia except for the patient with leukemia. Histologically, the main findings are in the lungs, including injury to the alveolar epithelial cells, hyaline membrane formation, and hyperplasia of type II pneumocytes, all components of diffuse alveolar damage. Consolidation by fibroblastic proliferation with extracellular matrix and fibrin forming clusters in airspaces is evident. In one patient, the consolidation consists of abundant intra-alveolar neutrophilic infiltration, consistent with superimposed bacterial bronchopneumonia. The liver exhibits mild lobular infiltration by small lymphocytes, and centrilobular sinusoidal dilation. Patchy necrosis is also seen. The heart shows only focal mild fibrosis and mild myocardial hypertrophy, changes likely related to the underlying conditions. In conclusion, the postmortem examinations show advanced diffuse alveolar damage, as well as superimposed bacterial pneumonia in some patients. Changes in the liver and heart are likely secondary or related to the underlying diseases.
Figures
Similar articles
-
[A pathological report of three COVID-19 cases by minimal invasive autopsies].Zhonghua Bing Li Xue Za Zhi. 2020 May 8;49(5):411-417. doi: 10.3760/cma.j.cn112151-20200312-00193. Zhonghua Bing Li Xue Za Zhi. 2020. PMID: 32172546 Chinese.
-
The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): Report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities.Cardiovasc Pathol. 2020 Sep-Oct;48:107233. doi: 10.1016/j.carpath.2020.107233. Epub 2020 May 7. Cardiovasc Pathol. 2020. PMID: 32434133 Free PMC article.
-
Late histopathologic characteristics of critically ill COVID-19 patients: Different phenotypes without evidence of invasive aspergillosis, a case series.J Crit Care. 2020 Oct;59:149-155. doi: 10.1016/j.jcrc.2020.07.002. Epub 2020 Jul 8. J Crit Care. 2020. PMID: 32674001 Free PMC article.
-
[Pathological changes of fatal coronavirus disease 2019 (COVID-19) in the lungs: report of 10 cases by postmortem needle autopsy].Zhonghua Bing Li Xue Za Zhi. 2020 Jun 8;49(6):568-575. doi: 10.3760/cma.j.cn112151-20200405-00291. Zhonghua Bing Li Xue Za Zhi. 2020. PMID: 32486534 Chinese.
-
Multi-organ pathological findings associated with COVID-19 in postmortem needle core biopsies in four patients and a review of the current literature.Rev Esp Patol. 2021 Oct-Dec;54(4):275-280. doi: 10.1016/j.patol.2020.09.003. Epub 2020 Oct 5. Rev Esp Patol. 2021. PMID: 34544557 Free PMC article. Review.
Cited by
-
Otilonium bromide ameliorates pulmonary fibrosis in mice through activating phosphatase PPM1A.Acta Pharmacol Sin. 2024 Aug 19. doi: 10.1038/s41401-024-01368-8. Online ahead of print. Acta Pharmacol Sin. 2024. PMID: 39160244
-
A novel extracellular vesicle paradigm for the treatment of COVID-19 induced acute respiratory distress syndrome (ARDS).Respir Med Case Rep. 2024 Jul 5;51:102087. doi: 10.1016/j.rmcr.2024.102087. eCollection 2024. Respir Med Case Rep. 2024. PMID: 39099663 Free PMC article.
-
Utilizing Feline Lentiviral Infection to Establish a Translational Model for COVID-19 in People with Human Immunodeficiency Virus Infection.Microorganisms. 2024 Jun 25;12(7):1289. doi: 10.3390/microorganisms12071289. Microorganisms. 2024. PMID: 39065058 Free PMC article.
-
Insight into COVID-19 associated liver injury: Mechanisms, evaluation, and clinical implications.Hepatol Forum. 2024 Jul 2;5(3):139-149. doi: 10.14744/hf.2023.2023.0025. eCollection 2024. Hepatol Forum. 2024. PMID: 39006140 Free PMC article. Review.
-
Aprotinin (II): Inhalational Administration for the Treatment of COVID-19 and Other Viral Conditions.Int J Mol Sci. 2024 Jun 29;25(13):7209. doi: 10.3390/ijms25137209. Int J Mol Sci. 2024. PMID: 39000315 Free PMC article. Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources